EUVIMEDEUVIMED entdecken
Open Access

Trends in prostate cancer diagnosis during the COVID-19 crisis: A report from one high-volume Japanese center

Daisuke Yamada, Taketo Kawai, Yusuke Sato, Yuta Yamada, Yoshiyuki Akiyama, Jimpei Miyakawa, Sayuri Takahashi, Haruki Kume

GHM Open · 2021

DOI: 10.35772/ghmo.2021.01024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GHM Open, 2021. Verfasst von Daisuke Yamada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

SARS-CoV-2agebiopsycoronavirusprostate-specific antigen (PSA)stage

Autor:innen und Institutionen

  • Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Urology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Zitieren

APA

Yamada, D., Kawai, T., Sato, Y., Yamada, Y., Akiyama, Y., Miyakawa, J., Takahashi, S., & Kume, H. (2021). Trends in prostate cancer diagnosis during the COVID-19 crisis: A report from one high-volume Japanese center. GHM Open. https://doi.org/10.35772/ghmo.2021.01024

Vancouver

Yamada D, Kawai T, Sato Y, Yamada Y, Akiyama Y, Miyakawa J, et al. Trends in prostate cancer diagnosis during the COVID-19 crisis: A report from one high-volume Japanese center. GHM Open. 2021. doi:10.35772/ghmo.2021.01024

BibTeX
@article{Yamada2021,
  author = {Yamada, Daisuke and Kawai, Taketo and Sato, Yusuke and Yamada, Yuta and Akiyama, Yoshiyuki and Miyakawa, Jimpei and Takahashi, Sayuri and Kume, Haruki},
  title = {Trends in prostate cancer diagnosis during the COVID-19 crisis: A report from one high-volume Japanese center},
  journal = {GHM Open},
  year = {2021},
  doi = {10.35772/ghmo.2021.01024}
}
Kostenlos starten →